论文信息 - Telmisartan in high-risk patients intolerant of ACE inhibitors – Authors' reply - 字舞流文

Telmisartan in high-risk patients intolerant of ACE inhibitors – Authors' reply

S. Yusuf | J. Pogue | C. Anderson | K. Teo | P. Sleight

[1] S. Yusuf,et al. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial , 2008, The Lancet.

[2] S. Yusuf,et al. Telmisartan to prevent recurrent stroke and cardiovascular events. , 2008, The New England journal of medicine.

[3] S. Yusuf,et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. , 2008, The New England journal of medicine.